Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death

The 60% of patients at highest risk for lung cancer in the National Lung Screening Trial accounted for 88% of the lung-cancer deaths prevented by low-dose CT screening. The use of risk assessment can improve the yield from low-dose CT screening for lung cancer. Lung cancer is the most common cause o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine Jg. 369; H. 3; S. 245 - 254
Hauptverfasser: Kovalchik, Stephanie A, Tammemagi, Martin, Berg, Christine D, Caporaso, Neil E, Riley, Tom L, Korch, Mary, Silvestri, Gerard A, Chaturvedi, Anil K, Katki, Hormuzd A
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Waltham, MA Massachusetts Medical Society 18.07.2013
Schlagworte:
ISSN:0028-4793, 1533-4406, 1533-4406
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The 60% of patients at highest risk for lung cancer in the National Lung Screening Trial accounted for 88% of the lung-cancer deaths prevented by low-dose CT screening. The use of risk assessment can improve the yield from low-dose CT screening for lung cancer. Lung cancer is the most common cause of cancer-related death in the United States, accounting for 28% and 26% of all cancer deaths among men and women, respectively. 1 Recent results from the National Lung Screening Trial (NLST), which showed a 20% reduction in lung-cancer mortality with low-dose computed tomography (CT) screening, as compared with chest radiography, highlighted the opportunity to reduce the burden of death from lung cancer. 2 With 94 million current and former smokers in the United States, 3 deciding which smokers to target for low-dose CT screening remains an important public health challenge, given the potential costs and harms . . .
AbstractList The 60% of patients at highest risk for lung cancer in the National Lung Screening Trial accounted for 88% of the lung-cancer deaths prevented by low-dose CT screening. The use of risk assessment can improve the yield from low-dose CT screening for lung cancer. Lung cancer is the most common cause of cancer-related death in the United States, accounting for 28% and 26% of all cancer deaths among men and women, respectively. 1 Recent results from the National Lung Screening Trial (NLST), which showed a 20% reduction in lung-cancer mortality with low-dose computed tomography (CT) screening, as compared with chest radiography, highlighted the opportunity to reduce the burden of death from lung cancer. 2 With 94 million current and former smokers in the United States, 3 deciding which smokers to target for low-dose CT screening remains an important public health challenge, given the potential costs and harms . . .
In the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among participants between the ages of 55 and 74 years with a minimum of 30 pack-years of smoking and no more than 15 years since quitting. It is not known whether the benefits and potential harms of such screening vary according to lung-cancer risk. We assessed the variation in efficacy, the number of false positive results, and the number of lung-cancer deaths prevented among 26,604 participants in the NLST who underwent low-dose CT screening, as compared with the 26,554 participants who underwent chest radiography, according to the quintile of 5-year risk of lung-cancer death (ranging from 0.15 to 0.55% in the lowest-risk group [quintile 1] to more than 2.00% in the highest-risk group [quintile 5]). The number of lung-cancer deaths per 10,000 person-years that were prevented in the CT-screening group, as compared with the radiography group, increased according to risk quintile (0.2 in quintile 1, 3.5 in quintile 2, 5.1 in quintile 3, 11.0 in quintile 4, and 12.0 in quintile 5; P=0.01 for trend). Across risk quintiles, there were significant decreasing trends in the number of participants with false positive results per screening-prevented lung-cancer death (1648 in quintile 1, 181 in quintile 2, 147 in quintile 3, 64 in quintile 4, and 65 in quintile 5). The 60% of participants at highest risk for lung-cancer death (quintiles 3 through 5) accounted for 88% of the screening-prevented lung-cancer deaths and for 64% of participants with false positive results. The 20% of participants at lowest risk (quintile 1) accounted for only 1% of prevented lung-cancer deaths. Screening with low-dose CT prevented the greatest number of deaths from lung cancer among participants who were at highest risk and prevented very few deaths among those at lowest risk. These findings provide empirical support for risk-based targeting of smokers for such screening. (Funded by the National Cancer Institute.).
BackgroundIn the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among participants between the ages of 55 and 74 years with a minimum of 30 pack-years of smoking and no more than 15 years since quitting. It is not known whether the benefits and potential harms of such screening vary according to lung-cancer risk.MethodsWe assessed the variation in efficacy, the number of false positive results, and the number of lung-cancer deaths prevented among 26,604 participants in the NLST who underwent low-dose CT screening, as compared with the 26,554 participants who underwent chest radiography, according to the quintile of 5-year risk of lung-cancer death (ranging from 0.15 to 0.55% in the lowest-risk group [quintile 1] to more than 2.00% in the highest-risk group [quintile 5]).ResultsThe number of lung-cancer deaths per 10,000 person-years that were prevented in the CT-screening group, as compared with the radiography group, increased according to risk quintile (0.2 in quintile 1, 3.5 in quintile 2, 5.1 in quintile 3, 11.0 in quintile 4, and 12.0 in quintile 5; P=0.01 for trend). Across risk quintiles, there were significant decreasing trends in the number of participants with false positive results per screening-prevented lung-cancer death (1648 in quintile 1, 181 in quintile 2, 147 in quintile 3, 64 in quintile 4, and 65 in quintile 5). The 60% of participants at highest risk for lung-cancer death (quintiles 3 through 5) accounted for 88% of the screening-prevented lung-cancer deaths and for 64% of participants with false positive results. The 20% of participants at lowest risk (quintile 1) accounted for only 1% of prevented lung-cancer deaths.ConclusionsScreening with low-dose CT prevented the greatest number of deaths from lung cancer among participants who were at highest risk and prevented very few deaths among those at lowest risk. These findings provide empirical support for risk-based targeting of smokers for such screening. (Funded by the National Cancer Institute.)
In the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among participants between the ages of 55 and 74 years with a minimum of 30 pack-years of smoking and no more than 15 years since quitting. It is not known whether the benefits and potential harms of such screening vary according to lung-cancer risk.BACKGROUNDIn the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among participants between the ages of 55 and 74 years with a minimum of 30 pack-years of smoking and no more than 15 years since quitting. It is not known whether the benefits and potential harms of such screening vary according to lung-cancer risk.We assessed the variation in efficacy, the number of false positive results, and the number of lung-cancer deaths prevented among 26,604 participants in the NLST who underwent low-dose CT screening, as compared with the 26,554 participants who underwent chest radiography, according to the quintile of 5-year risk of lung-cancer death (ranging from 0.15 to 0.55% in the lowest-risk group [quintile 1] to more than 2.00% in the highest-risk group [quintile 5]).METHODSWe assessed the variation in efficacy, the number of false positive results, and the number of lung-cancer deaths prevented among 26,604 participants in the NLST who underwent low-dose CT screening, as compared with the 26,554 participants who underwent chest radiography, according to the quintile of 5-year risk of lung-cancer death (ranging from 0.15 to 0.55% in the lowest-risk group [quintile 1] to more than 2.00% in the highest-risk group [quintile 5]).The number of lung-cancer deaths per 10,000 person-years that were prevented in the CT-screening group, as compared with the radiography group, increased according to risk quintile (0.2 in quintile 1, 3.5 in quintile 2, 5.1 in quintile 3, 11.0 in quintile 4, and 12.0 in quintile 5; P=0.01 for trend). Across risk quintiles, there were significant decreasing trends in the number of participants with false positive results per screening-prevented lung-cancer death (1648 in quintile 1, 181 in quintile 2, 147 in quintile 3, 64 in quintile 4, and 65 in quintile 5). The 60% of participants at highest risk for lung-cancer death (quintiles 3 through 5) accounted for 88% of the screening-prevented lung-cancer deaths and for 64% of participants with false positive results. The 20% of participants at lowest risk (quintile 1) accounted for only 1% of prevented lung-cancer deaths.RESULTSThe number of lung-cancer deaths per 10,000 person-years that were prevented in the CT-screening group, as compared with the radiography group, increased according to risk quintile (0.2 in quintile 1, 3.5 in quintile 2, 5.1 in quintile 3, 11.0 in quintile 4, and 12.0 in quintile 5; P=0.01 for trend). Across risk quintiles, there were significant decreasing trends in the number of participants with false positive results per screening-prevented lung-cancer death (1648 in quintile 1, 181 in quintile 2, 147 in quintile 3, 64 in quintile 4, and 65 in quintile 5). The 60% of participants at highest risk for lung-cancer death (quintiles 3 through 5) accounted for 88% of the screening-prevented lung-cancer deaths and for 64% of participants with false positive results. The 20% of participants at lowest risk (quintile 1) accounted for only 1% of prevented lung-cancer deaths.Screening with low-dose CT prevented the greatest number of deaths from lung cancer among participants who were at highest risk and prevented very few deaths among those at lowest risk. These findings provide empirical support for risk-based targeting of smokers for such screening. (Funded by the National Cancer Institute.).CONCLUSIONSScreening with low-dose CT prevented the greatest number of deaths from lung cancer among participants who were at highest risk and prevented very few deaths among those at lowest risk. These findings provide empirical support for risk-based targeting of smokers for such screening. (Funded by the National Cancer Institute.).
Author Caporaso, Neil E
Katki, Hormuzd A
Chaturvedi, Anil K
Korch, Mary
Tammemagi, Martin
Berg, Christine D
Kovalchik, Stephanie A
Riley, Tom L
Silvestri, Gerard A
Author_xml – sequence: 1
  givenname: Stephanie A
  surname: Kovalchik
  fullname: Kovalchik, Stephanie A
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 2
  givenname: Martin
  surname: Tammemagi
  fullname: Tammemagi, Martin
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 3
  givenname: Christine D
  surname: Berg
  fullname: Berg, Christine D
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 4
  givenname: Neil E
  surname: Caporaso
  fullname: Caporaso, Neil E
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 5
  givenname: Tom L
  surname: Riley
  fullname: Riley, Tom L
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 6
  givenname: Mary
  surname: Korch
  fullname: Korch, Mary
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 7
  givenname: Gerard A
  surname: Silvestri
  fullname: Silvestri, Gerard A
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 8
  givenname: Anil K
  surname: Chaturvedi
  fullname: Chaturvedi, Anil K
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
– sequence: 9
  givenname: Hormuzd A
  surname: Katki
  fullname: Katki, Hormuzd A
  organization: From the Divisions of Cancer Epidemiology and Genetics (S.A.K., N.E.C., A.K.C., H.A.K.) and Cancer Prevention (C.D.B.), National Cancer Institute, National Institutes of Health, and Information Management Services (T.L.R., M.K.) — all in Rockville, MD; the Department of Community Health Sciences, Brock University, St. Catharines, ON, Canada (M.T.); and the Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston (G.A.S.)
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27488130$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23863051$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1v1DAQxS1URLeFI1cUCSFxCdixHdsXpGrb8qEtSLCcLceZ7HpJ7NZOQP3vcegWaKX6MpbmN09v5h2hAx88IPSc4DcE8_rt57NPF8EQionk5BFaEE5pyRiuD9AC40qWTCh6iI5S2uH8CFNP0GFFZU0xJwt0sTZxA6PzmyJ0xSr8Kk9DgmK5Lr7ZCODnxom1IbbzbwzFuIXiq0s__uCT35RL4y3E4hTMuH2KHnemT_BsX4_R9_Oz9fJDufry_uPyZFVazshYtljwitlWKYwbripZibpTuJPSVFXdWEGkwNCCEp0RBKBpMO6EpERwQisF9Bi9u9G9nJoBWgt-jKbXl9ENJl7rYJy-2_Fuqzfhp6ZZpeYsC7zeC8RwNUEa9eCShb43HsKUNMkHJKJWRGX05T10F6bo83ozRZjEDM-CL_539NfK7aUz8GoPmGRN38V8Npf-cYJJmVPMHL3hbAwpRei0daMZXZgXcb0mWM-56zu556ny3tSt8EP83s0wJO1hNzzA_QbX2rbD
CODEN NEJMAG
CitedBy_id crossref_primary_10_1007_s12254_019_0501_x
crossref_primary_10_1186_s12880_023_01143_x
crossref_primary_10_1186_s12885_016_2316_z
crossref_primary_10_1007_s00761_016_0074_9
crossref_primary_10_1371_journal_pone_0108465
crossref_primary_10_1093_tbm_ibab115
crossref_primary_10_1200_JCO_2016_69_2467
crossref_primary_10_3390_cancers17060942
crossref_primary_10_1200_JCO_2015_60_9818
crossref_primary_10_1007_s00330_020_07275_w
crossref_primary_10_1016_j_jtho_2016_05_018
crossref_primary_10_1200_JCO_2015_63_1713
crossref_primary_10_1371_journal_pmed_1002277
crossref_primary_10_1136_bmjopen_2020_037075
crossref_primary_10_1016_j_medcle_2016_11_004
crossref_primary_10_1097_MCP_0000000000000287
crossref_primary_10_1164_rccm_201505_1040OC
crossref_primary_10_14309_ajg_0000000000001355
crossref_primary_10_1016_S2213_2600_16_30200_4
crossref_primary_10_1164_rccm_202201_0126ST
crossref_primary_10_1148_radiol_2017161659
crossref_primary_10_1097_RTI_0000000000000135
crossref_primary_10_1002_ijc_33578
crossref_primary_10_1371_journal_pone_0306163
crossref_primary_10_1371_journal_pone_0308106
crossref_primary_10_1016_S1470_2045_14_71108_8
crossref_primary_10_1183_13993003_00506_2019
crossref_primary_10_1186_s40985_015_0010_3
crossref_primary_10_1016_j_ejso_2020_02_015
crossref_primary_10_1586_17476348_2014_937428
crossref_primary_10_1007_s40471_017_0126_8
crossref_primary_10_1378_chest_14_0670
crossref_primary_10_1002_mp_15607
crossref_primary_10_7326_M19_1263
crossref_primary_10_1007_s00520_018_4159_4
crossref_primary_10_1164_rccm_201504_0756UP
crossref_primary_10_1378_chest_14_3020
crossref_primary_10_1016_j_jtho_2023_05_024
crossref_primary_10_1097_CPM_0000000000000212
crossref_primary_10_1177_0969141317727771
crossref_primary_10_1016_j_jtho_2025_01_008
crossref_primary_10_1136_thoraxjnl_2015_207140
crossref_primary_10_1016_j_mcna_2022_07_007
crossref_primary_10_1161_ATVBAHA_114_304562
crossref_primary_10_1177_09691413231190785
crossref_primary_10_1016_S2213_2600_21_00164_8
crossref_primary_10_1016_j_mcna_2020_08_002
crossref_primary_10_1186_s13584_025_00696_2
crossref_primary_10_1016_S1470_2045_21_00590_8
crossref_primary_10_1038_s41416_021_01278_0
crossref_primary_10_1093_ije_dyw118
crossref_primary_10_3389_fonc_2020_580809
crossref_primary_10_1007_s00408_014_9636_z
crossref_primary_10_1093_jnci_djae148
crossref_primary_10_1586_14737159_2016_1149469
crossref_primary_10_1016_j_athoracsur_2018_06_058
crossref_primary_10_1016_j_cger_2017_06_008
crossref_primary_10_1378_chest_14_2500
crossref_primary_10_1093_ije_dyw125
crossref_primary_10_1056_NEJMoa1312547
crossref_primary_10_1016_j_chest_2020_12_004
crossref_primary_10_1097_CM9_0000000000002353
crossref_primary_10_1186_s12913_021_06540_y
crossref_primary_10_1016_j_chest_2021_02_050
crossref_primary_10_1093_qjmed_hcab030
crossref_primary_10_1371_journal_pmed_1001764
crossref_primary_10_1016_j_lungcan_2015_11_003
crossref_primary_10_1001_jamanetworkopen_2020_0409
crossref_primary_10_1016_j_jhep_2018_12_009
crossref_primary_10_1164_rccm_201503_0526LE
crossref_primary_10_1097_JTO_0000000000000666
crossref_primary_10_1097_COC_0000000000000740
crossref_primary_10_35371_aoem_2021_33_e22
crossref_primary_10_1016_j_lungcan_2015_03_021
crossref_primary_10_1016_j_arbr_2016_02_020
crossref_primary_10_5694_mja13_11144
crossref_primary_10_1016_j_jacr_2013_09_017
crossref_primary_10_1016_S1470_2045_17_30861_6
crossref_primary_10_1097_JHQ_0000000000000089
crossref_primary_10_1136_thoraxjnl_2020_214703
crossref_primary_10_2196_32399
crossref_primary_10_1016_j_cmpb_2022_106660
crossref_primary_10_1093_jnci_djaa211
crossref_primary_10_1093_jnci_dju118
crossref_primary_10_1016_j_amepre_2020_10_014
crossref_primary_10_1136_thoraxjnl_2015_208107
crossref_primary_10_1016_j_resinv_2013_10_001
crossref_primary_10_1016_j_jtho_2025_01_021
crossref_primary_10_1513_AnnalsATS_201810_690RL
crossref_primary_10_1016_j_jtho_2025_01_024
crossref_primary_10_1007_s10654_016_0180_4
crossref_primary_10_1158_1078_0432_CCR_13_0731
crossref_primary_10_1053_j_gastro_2020_11_052
crossref_primary_10_1097_JTO_0000000000000278
crossref_primary_10_1183_09031936_00033015
crossref_primary_10_7326_M17_2701
crossref_primary_10_1186_s12885_017_3175_y
crossref_primary_10_1038_s41571_019_0231_3
crossref_primary_10_1155_2018_1296246
crossref_primary_10_1016_j_jacr_2018_09_025
crossref_primary_10_1016_j_jtho_2020_09_010
crossref_primary_10_1038_s41420_019_0207_1
crossref_primary_10_1183_20734735_0190_2023
crossref_primary_10_1164_rccm_202008_3053ST
crossref_primary_10_1109_ACCESS_2020_2986388
crossref_primary_10_1371_journal_pone_0222183
crossref_primary_10_1097_PPO_0000000000000274
crossref_primary_10_1513_AnnalsATS_202010_1276OC
crossref_primary_10_1093_ntr_ntaa192
crossref_primary_10_1016_j_annepidem_2022_10_014
crossref_primary_10_1016_j_chest_2018_03_021
crossref_primary_10_1136_jmedgenet_2020_107399
crossref_primary_10_1038_nrclinonc_2016_101
crossref_primary_10_1097_JTO_0000000000000283
crossref_primary_10_1136_thoraxjnl_2014_205271
crossref_primary_10_1016_j_mcna_2017_03_008
crossref_primary_10_1513_AnnalsATS_201902_102OC
crossref_primary_10_1016_j_suc_2015_05_006
crossref_primary_10_1136_thoraxjnl_2016_208789
crossref_primary_10_1177_0272989X17696994
crossref_primary_10_1016_j_amjmed_2015_10_030
crossref_primary_10_1200_JGO_2017_1700016
crossref_primary_10_7326_M19_2797
crossref_primary_10_1146_annurev_publhealth_040617_014208
crossref_primary_10_1016_j_ijrobp_2021_11_006
crossref_primary_10_5694_mja13_11110
crossref_primary_10_1164_rccm_201508_1594ED
crossref_primary_10_1007_s00330_015_3697_0
crossref_primary_10_1016_j_lungcan_2020_07_007
crossref_primary_10_1111_hex_14143
crossref_primary_10_1007_s00330_020_06727_7
crossref_primary_10_1016_j_jacr_2024_12_005
crossref_primary_10_1002_ijc_30673
crossref_primary_10_1016_j_ijrobp_2024_02_048
crossref_primary_10_1148_radiol_2018181220
crossref_primary_10_1016_j_acra_2014_10_011
crossref_primary_10_1186_s12916_024_03445_5
crossref_primary_10_1007_s40137_013_0027_9
crossref_primary_10_3892_ijo_2014_2495
crossref_primary_10_3390_cancers12061672
crossref_primary_10_1371_journal_pone_0207686
crossref_primary_10_1016_j_rmr_2021_04_007
crossref_primary_10_1371_journal_pone_0205264
crossref_primary_10_1186_s12889_019_6419_8
crossref_primary_10_1097_JTO_0000000000000060
crossref_primary_10_1183_09059180_00009013
crossref_primary_10_2217_lmt_14_5
crossref_primary_10_1007_s13665_016_0139_7
crossref_primary_10_1136_bmjopen_2021_055007
crossref_primary_10_1016_j_arbres_2014_09_019
crossref_primary_10_1016_j_jtho_2021_07_025
crossref_primary_10_1007_s00117_016_0152_4
crossref_primary_10_1164_rccm_201511_2270ED
crossref_primary_10_1093_jnci_djv199
crossref_primary_10_1007_s10552_019_01161_7
crossref_primary_10_1183_13993003_00128_2023
crossref_primary_10_1186_s12885_017_3173_0
crossref_primary_10_1016_j_lungcan_2021_04_005
crossref_primary_10_3390_cancers6021157
crossref_primary_10_1016_j_jacr_2015_09_016
crossref_primary_10_1136_thoraxjnl_2020_215156
crossref_primary_10_1111_clr_13636
crossref_primary_10_1164_rccm_201506_1160ED
crossref_primary_10_1093_carcin_bgaa094
crossref_primary_10_1016_j_jtho_2023_11_002
crossref_primary_10_1016_j_amepre_2018_07_030
crossref_primary_10_1136_thoraxjnl_2020_214626
crossref_primary_10_1158_1940_6207_CAPR_13_0371
crossref_primary_10_1016_j_clon_2016_08_001
crossref_primary_10_1016_j_ctarc_2022_100561
crossref_primary_10_1200_JCO_2014_59_9746
crossref_primary_10_1136_bmjonc_2024_000663
crossref_primary_10_1016_j_jtho_2016_03_012
crossref_primary_10_1016_j_chest_2021_07_003
crossref_primary_10_1016_j_jtho_2025_06_008
crossref_primary_10_1111_resp_13963
crossref_primary_10_1016_j_eswa_2025_128508
crossref_primary_10_1097_MCP_0000000000000451
crossref_primary_10_7326_M14_2327
crossref_primary_10_1002_tre_778
crossref_primary_10_1136_thoraxjnl_2017_211107
crossref_primary_10_1136_jech_2014_204079
crossref_primary_10_5888_pcd13_160093
crossref_primary_10_1159_000365234
crossref_primary_10_1183_16000617_0288_2020
crossref_primary_10_1259_bjr_20140416
crossref_primary_10_1164_rccm_201502_0259OC
crossref_primary_10_1016_j_lungcan_2015_05_004
crossref_primary_10_1097_JTO_0000000000000593
crossref_primary_10_1016_j_annepidem_2021_06_008
crossref_primary_10_1164_rccm_201409_1747LE
crossref_primary_10_1159_000357049
crossref_primary_10_1093_pubmed_fdaa063
crossref_primary_10_1097_CCO_0000000000000055
crossref_primary_10_1177_23814683241252786
crossref_primary_10_1016_j_ijrobp_2014_06_064
crossref_primary_10_1016_j_athoracsur_2020_10_037
crossref_primary_10_1183_09031936_00164513
crossref_primary_10_1016_j_chest_2022_02_031
crossref_primary_10_1016_j_pccm_2023_11_002
crossref_primary_10_1016_j_chest_2023_04_040
crossref_primary_10_1016_j_lanepe_2025_101221
crossref_primary_10_1016_S1470_2045_17_30597_1
crossref_primary_10_1016_j_jtho_2019_05_012
crossref_primary_10_1371_journal_pone_0110157
crossref_primary_10_5694_mja16_00043
crossref_primary_10_1093_aje_kwv158
crossref_primary_10_1186_s12889_017_4114_1
crossref_primary_10_7326_M22_1325
crossref_primary_10_1016_j_chest_2021_01_070
crossref_primary_10_12771_emj_2025_00052
crossref_primary_10_1016_j_lungcan_2022_01_015
crossref_primary_10_1016_j_jcrpr_2017_05_003
crossref_primary_10_1001_jama_2021_0377
crossref_primary_10_1164_rccm_201707_1504ED
crossref_primary_10_1001_jamanetworkopen_2025_2172
crossref_primary_10_1007_s11912_020_00968_x
crossref_primary_10_2105_AJPH_2018_304518
crossref_primary_10_1001_jamanetworkopen_2021_1974
crossref_primary_10_1016_j_jclinepi_2017_10_021
crossref_primary_10_1002_cncr_34947
crossref_primary_10_1097_CPM_0000000000000050
crossref_primary_10_1164_rccm_201902_0294OC
crossref_primary_10_1164_rccm_201805_0986ST
crossref_primary_10_1007_s00103_018_2834_8
crossref_primary_10_1164_rccm_201410_1777CI
crossref_primary_10_1136_oemed_2018_105464
crossref_primary_10_1164_rccm_201508_1671ST
crossref_primary_10_2217_cer_2020_0033
crossref_primary_10_1259_bjr_20140530
crossref_primary_10_1136_thoraxjnl_2018_212812
crossref_primary_10_1183_23120541_00221_2019
crossref_primary_10_1007_s12254_013_0127_3
crossref_primary_10_1177_0272989X19875966
crossref_primary_10_1513_AnnalsATS_201909_659OC
crossref_primary_10_7326_M18_3667
crossref_primary_10_1016_j_jacr_2014_07_038
crossref_primary_10_1200_JCO_2017_72_4203
crossref_primary_10_1016_j_ccm_2017_09_003
crossref_primary_10_1183_13993003_03386_2020
crossref_primary_10_1002_cncr_29222
crossref_primary_10_1016_j_lungcan_2019_05_028
crossref_primary_10_1016_j_pec_2015_07_010
crossref_primary_10_1136_bmj_k4245
crossref_primary_10_1259_bjr_20170401
crossref_primary_10_1038_s44276_023_00006_w
crossref_primary_10_1016_j_aca_2017_09_021
crossref_primary_10_1158_2159_8290_CD_20_1165
crossref_primary_10_1164_rccm_201407_1210OC
crossref_primary_10_1513_AnnalsATS_201911_857OC
crossref_primary_10_1164_rccm_201411_2125CP
crossref_primary_10_3109_08958378_2014_955932
crossref_primary_10_1177_0969141316689111
crossref_primary_10_5888_pcd12_150112
crossref_primary_10_1016_j_ccm_2019_10_004
crossref_primary_10_7326_M18_1350
crossref_primary_10_1016_j_clinthera_2018_03_003
crossref_primary_10_1053_j_seminoncol_2017_02_003
crossref_primary_10_1136_bmjresp_2016_000166
crossref_primary_10_3892_ijo_2016_3330
crossref_primary_10_1016_j_ejca_2020_04_035
crossref_primary_10_1016_j_chest_2020_08_2112
crossref_primary_10_1016_j_chest_2018_01_016
crossref_primary_10_1038_s44276_024_00082_6
crossref_primary_10_1161_CIRCOUTCOMES_115_001693
crossref_primary_10_4103_fjs_fjs_114_22
crossref_primary_10_12688_f1000research_7313_1
crossref_primary_10_1093_rpd_ncaa212
crossref_primary_10_1371_journal_pmed_1002225
crossref_primary_10_1093_jnci_djv286
crossref_primary_10_1164_rccm_201503_0565ED
crossref_primary_10_1513_AnnalsATS_201602_091OC
crossref_primary_10_1158_1940_6207_CAPR_13_0206
crossref_primary_10_1016_j_arbr_2015_02_015
crossref_primary_10_1093_aje_kww159
crossref_primary_10_1038_s41467_025_63471_6
crossref_primary_10_1016_j_hlc_2017_11_004
crossref_primary_10_1016_j_cllc_2020_05_018
crossref_primary_10_1097_RTI_0000000000000221
crossref_primary_10_1001_jamanetworkopen_2023_3273
crossref_primary_10_1016_j_arbres_2016_02_016
crossref_primary_10_1056_NEJMcp1404071
crossref_primary_10_1164_rccm_201410_1848OC
crossref_primary_10_1183_13993003_01613_2021
crossref_primary_10_1371_journal_pone_0173119
crossref_primary_10_1513_AnnalsATS_201701_008ED
crossref_primary_10_1164_rccm_201705_0914OC
crossref_primary_10_1186_s12885_017_3287_4
crossref_primary_10_1136_thorax_2022_219778
crossref_primary_10_1136_thoraxjnl_2021_217142
crossref_primary_10_1186_s12880_015_0060_5
crossref_primary_10_1038_srep26582
crossref_primary_10_1093_jnci_djy041
crossref_primary_10_1016_j_suc_2017_03_006
crossref_primary_10_1016_j_pop_2014_02_007
crossref_primary_10_3389_fonc_2020_00318
crossref_primary_10_3390_cancers13143496
crossref_primary_10_1158_1055_9965_EPI_23_1491
crossref_primary_10_1001_jamanetworkopen_2019_0204
crossref_primary_10_1016_j_jclinepi_2025_111689
crossref_primary_10_1038_s41598_019_46643_5
crossref_primary_10_1053_j_semtcvs_2017_11_008
crossref_primary_10_1146_annurev_med_020917_053556
crossref_primary_10_1111_imj_12755
crossref_primary_10_1371_journal_pone_0195441
crossref_primary_10_1007_s12672_023_00773_5
crossref_primary_10_1038_s41571_020_00432_6
crossref_primary_10_1088_1742_6596_1378_3_032010
crossref_primary_10_1164_rccm_201408_1475OC
crossref_primary_10_3390_diagnostics14050522
crossref_primary_10_1002_cncr_28749
crossref_primary_10_1164_rccm_201510_2096ED
crossref_primary_10_1016_j_jtho_2024_05_001
crossref_primary_10_1016_j_ypmed_2016_06_006
crossref_primary_10_1007_s00330_015_3826_9
crossref_primary_10_1016_j_jtho_2025_01_003
crossref_primary_10_1002_cncr_35382
crossref_primary_10_1016_j_chest_2020_10_040
crossref_primary_10_1158_0008_5472_CAN_20_3454
crossref_primary_10_1111_hex_12481
crossref_primary_10_1002_cam4_5638
crossref_primary_10_1136_thoraxjnl_2018_212457
crossref_primary_10_1186_s12885_018_4430_6
crossref_primary_10_7326_M15_0055
crossref_primary_10_1016_j_chest_2021_06_063
crossref_primary_10_1016_j_thorsurg_2014_12_004
crossref_primary_10_7326_M17_2561
crossref_primary_10_1001_jamanetworkopen_2020_33769
crossref_primary_10_1097_JTO_0000000000000210
crossref_primary_10_1186_1745_6673_9_14
crossref_primary_10_1371_journal_pone_0106668
crossref_primary_10_1080_17476348_2019_1638766
crossref_primary_10_1164_rccm_201403_0588ED
crossref_primary_10_7326_M19_2869
crossref_primary_10_1007_s00330_014_3361_0
crossref_primary_10_1016_j_ijrobp_2020_12_014
crossref_primary_10_1098_rsob_170070
crossref_primary_10_1513_AnnalsATS_202408_863OC
crossref_primary_10_1007_s00408_013_9517_x
crossref_primary_10_1200_JCO_2016_71_3214
crossref_primary_10_1186_s12890_016_0178_4
crossref_primary_10_2196_26256
crossref_primary_10_3389_fonc_2023_1085434
crossref_primary_10_1001_jamanetworkopen_2023_37889
crossref_primary_10_7326_M23_3250
crossref_primary_10_1053_j_semtcvs_2013_08_001
crossref_primary_10_1136_bmj_2024_081674
crossref_primary_10_1097_RTI_0000000000000233
crossref_primary_10_1002_ijc_30727
crossref_primary_10_1089_lgbt_2016_0039
crossref_primary_10_1016_j_jtcvs_2019_11_141
crossref_primary_10_1093_jnci_djaa013
crossref_primary_10_1093_jnci_djab224
crossref_primary_10_3390_cancers16122200
crossref_primary_10_1016_j_redii_2025_100062
crossref_primary_10_1097_00130404_201707000_00010
crossref_primary_10_1378_chest_14_1585
crossref_primary_10_1016_j_jfma_2019_11_006
crossref_primary_10_1158_1078_0432_CCR_14_0748
crossref_primary_10_1183_23120541_00579_2022
crossref_primary_10_1007_s00117_013_2600_8
crossref_primary_10_1016_j_chest_2021_06_066
crossref_primary_10_1016_j_jtho_2021_10_001
crossref_primary_10_1093_jnci_djz165
Cites_doi 10.1001/jama.2012.6096
10.6004/jnccn.2012.0022
10.1001/2012.jama.11892
10.1093/jnci/dji430
10.7326/0003-4819-155-8-201110180-00364
10.7326/0003-4819-157-8-201210160-00524
10.1001/jama.2012.216988
10.1056/NEJMc1111935
10.2307/2532098
10.1002/sim.1187
10.1258/jms.2012.012010
10.1158/1078-0432.CCR-07-4534
10.1056/NEJMoa1102873
10.1016/j.jtcvs.2012.05.060
10.3322/caac.21172
10.1056/NEJMe1103776
10.1158/1940-6207.CAPR-11-0026
10.1093/jnci/djq434
10.1093/jnci/djr173
10.1148/radiol.10091808
10.1093/jnci/djk153
10.7326/0003-4819-157-4-201208210-00004
10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
10.1093/annonc/mds476
10.3322/caac.21166
10.1038/sj.bjc.6604158
10.7326/0003-4819-155-8-201110180-00367
10.1056/NEJMoa1211776
10.1093/jnci/95.6.470
10.1001/jama.2012.5521
ContentType Journal Article
Copyright Copyright © 2013 Massachusetts Medical Society. All rights reserved.
2014 INIST-CNRS
Copyright © 2013 Massachusetts Medical Society. 2013
Copyright_xml – notice: Copyright © 2013 Massachusetts Medical Society. All rights reserved.
– notice: 2014 INIST-CNRS
– notice: Copyright © 2013 Massachusetts Medical Society. 2013
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1056/NEJMoa1301851
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central Essentials
Biological Science Collection
eLibrary Curriculum
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep (ProQuest)
SciTech Premium Collection
New England Journal of Medicine
Biological Sciences
Consumer Health Database
Healthcare Administration Database
Medical Database
Psychology Database
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
ProQuest One Psychology
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-4406
EndPage 254
ExternalDocumentID PMC3783654
3023369621
23863051
27488130
10_1056_NEJMoa1301851
NJ201307183690309
Genre Original Article
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: N01 CN075022
– fundername: NCI NIH HHS
  grantid: U01 CA080098
– fundername: NCI NIH HHS
  grantid: N01 CN025518
– fundername: NCI NIH HHS
  grantid: N01 CN025516
– fundername: NCI NIH HHS
  grantid: U01 CA079778
– fundername: NCI NIH HHS
  grantid: N01 CN025514
– fundername: NCI NIH HHS
  grantid: N02 CN063300
– fundername: NCI NIH HHS
  grantid: N01 CN025512
– fundername: NCI NIH HHS
  grantid: N01 CN025524
– fundername: NCI NIH HHS
  grantid: N01 CN025515
– fundername: National Cancer Institute : NCI
  grantid: Z99 CA999999 || CA
GroupedDBID -
0R
0WA
123
186
1KJ
1VV
29N
2KS
2WC
34G
39C
3V.
4
4.4
53G
55
5D0
5RE
68V
7FN
7RV
7X7
85S
8AO
8C1
8FE
8FH
8FI
AACLI
AAEJM
AAIKC
AAJWC
AALRV
AAPBV
AAQQT
AARDX
AAWTL
ABACO
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQIJ
ABUWG
ABWJO
ACGFS
ACGOD
ACJLH
ACNCT
ACPRK
ACRZS
ADBBV
ADBIT
ADCBC
ADRHT
AENEX
AETEA
AFFNX
AFHKK
AFKRA
AGFXO
AGNAY
AHMBA
AJJEV
AJVPN
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
AZQEC
BBAFP
BBNVY
BCR
BCU
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C45
CJ0
CO
CS3
DCD
DU5
DWQXO
DZ
EBS
EJD
ET
EX3
F20
F5P
FD8
FM.
FYUFA
GJ
GNUQQ
GUQSH
H13
HCIFZ
HZ
IH2
K-O
KM
KOO
L7B
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MVM
N9A
NAPCQ
NEJ
O9-
OK1
OMK
OVD
P-O
P-S
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QJJ
RHI
RWL
RXW
S10
S6N
SJFOW
SJN
TAE
TAF
TEORI
TN5
TUQ
TWZ
UCV
UKR
UMD
UQL
VQA
W2G
WH7
WOQ
WOW
X
X7M
XJT
XYN
XZL
YCJ
YNT
YRY
YZZ
ZA5
ZHY
ZKB
---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
0R~
1CY
36B
6TJ
AAMNW
AAYXX
ABBLC
ABCQX
ABDQB
ABJNI
ABUFD
ACKOT
ACPFK
ADUKH
ADXHL
AERZD
AFFHD
AGHSJ
BYPQX
CCPQU
CITATION
HF~
HMCUK
HZ~
N4W
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PSYQQ
UKHRP
YFH
YR2
YR5
YYP
ZCA
ZR0
ZVN
~KM
3O-
41~
8WZ
9M8
A6W
AAQOH
AAUTI
AAYOK
ABDPE
ABEFU
ACPVT
ACTDY
AFFDN
AFOSN
AJUXI
ALIPV
D0S
FA8
IQODW
J5H
LPU
MQT
NHB
OHT
QZG
SKT
UBX
UIG
WHG
XOL
YHZ
YQI
YQJ
YYQ
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7XB
BEC
K0Y
MBDVC
PKEHL
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c541t-d07524cd9900b5928276f90f88a226bc71870ede97fa71eebb00f7831751329e3
IEDL.DBID DCD
ISICitedReferencesCount 478
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000321945800010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0028-4793
1533-4406
IngestDate Tue Nov 04 02:01:51 EST 2025
Fri Sep 05 07:13:29 EDT 2025
Mon Dec 01 00:11:28 EST 2025
Mon Jul 21 06:05:10 EDT 2025
Wed Apr 02 07:26:44 EDT 2025
Tue Nov 18 21:32:32 EST 2025
Sat Nov 29 03:54:36 EST 2025
Tue Dec 21 14:39:01 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Lung disease
Radiodiagnosis
Targeting
Respiratory disease
Lung cancer
Low dose
Mortality
Risk
Malignant tumor
Medical screening
Medicine
Risk factor
Medical imagery
Bronchus disease
Death
Computerized axial tomography
Cancer
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-d07524cd9900b5928276f90f88a226bc71870ede97fa71eebb00f7831751329e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.nejm.org/doi/pdf/10.1056/NEJMoa1301851?articleTools=true
PMID 23863051
PQID 1401480404
PQPubID 40644
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3783654
proquest_miscellaneous_1406176919
proquest_journals_1401480404
pubmed_primary_23863051
pascalfrancis_primary_27488130
crossref_citationtrail_10_1056_NEJMoa1301851
crossref_primary_10_1056_NEJMoa1301851
mms_nejm_10_1056_NEJMoa1301851
PublicationCentury 2000
PublicationDate 2013-07-18
PublicationDateYYYYMMDD 2013-07-18
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07-18
  day: 18
PublicationDecade 2010
PublicationPlace Waltham, MA
PublicationPlace_xml – name: Waltham, MA
– name: United States
– name: Boston
PublicationTitle The New England journal of medicine
PublicationTitleAlternate N Engl J Med
PublicationYear 2013
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References Jett, JR, Midthun, DE (r014) 2011; 155
O'Connor, GT, Hatabu, H (r032) 2012; 307
Boiselle, PM (r029) 2013; 309
Young, RP, Hopkins, RJ, Midthun, DE (r013) 2012; 308
Heuvers, ME, Stricker, BH, Aerts, JG (r030) 2012; 366
Siegel, R, Naishadham, D, Jemal, A (r001) 2013; 63
Bach, PB, Kattan, MW, Thornquist, MD (r023) 2003; 95
Bach, PB, Mirkin, JN, Oliver, TK (r004) 2012; 307
Couraud, S, Cortot, AB, Greillier, L (r006) 2013; 24
Aberle, DR, Adams, AM, Berg, CD (r017) 2010; 102
Tammemagi, MC, Katki, HA, Hocking, WG (r010) 2013; 368
Taylor, JM, Ankerst, DP, Andridge, RR (r020) 2008; 14
Benichou, J, Gail, MH (r018) 1990; 46
Sox, HC (r031) 2011; 365
Jaklitsch, MT, Jacobson, FL, Austin, JH (r008) 2012; 144
Pinsky, PF, Berg, CD (r011) 2012; 19
Spitz, MR, Hong, WK, Amos, CI (r024) 2007; 99
Oken, MM, Marcus, PM, Hu, P (r021) 2005; 97
Tibshirani, R (r019) 1997; 16
Tammemagi, CM, Pinsky, PF, Caporaso, NE (r026) 2011; 103
Raji, OY, Duffy, SW, Agbaje, OF (r009) 2012; 157
r033
(r002) 2011; 365
Wood, DE, Eapen, GA, Ettinger, DS (r007) 2012; 10
Bach, PB, Gould, MK (r015) 2012; 157
Wender, R, Fontham, ET, Barrera, E (r005) 2013; 63
Thompson, SG, Higgins, JP (r022) 2002; 21
Cassidy, A, Myles, JP, van Tongeren, M (r025) 2008; 98
(r003) 2009; 58
(r016) 2011; 258
r027
Silvestri, GA (r028) 2011; 155
Maisonneuve, P, Bagnardi, V, Bellomi, M (r012) 2011; 4
r020
r021
r022
r001
r023
r017
r018
r019
r013
r014
r015
r016
r031
r010
r032
Wood DE (r007) 2012; 10
r011
r012
r030
r006
r028
r029
r008
r009
r002
r024
r025
r004
r026
r005
24511598 - Rofo. 2014 Jan;186(1):8.
24002872 - Dtsch Med Wochenschr. 2013 Sep;138(36):1754. doi: 10.1055/s-0032-1329057.
References_xml – volume: 14
  start-page: 5977
  year: 2008
  end-page: 5983
  ident: r020
  article-title: Validation of biomarker-based risk prediction models.
  publication-title: Clin Cancer Res
– volume: 157
  start-page: 242
  year: 2012
  end-page: 250
  ident: r009
  article-title: Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.
  publication-title: Ann Intern Med
– volume: 366
  start-page: 192
  year: 2012
  end-page: 193
  ident: r030
  article-title: Generalizing lung-cancer screening results.
  publication-title: N Engl J Med
– volume: 308
  start-page: 1320
  year: 2012
  end-page: 1320
  ident: r013
  article-title: Computed tomographic screening for lung cancer.
  publication-title: JAMA
– volume: 10
  start-page: 240
  year: 2012
  end-page: 265
  ident: r007
  article-title: Lung cancer screening.
  publication-title: J Natl Compr Canc Netw
– volume: 365
  start-page: 455
  year: 2011
  end-page: 457
  ident: r031
  article-title: Better evidence about screening for lung cancer.
  publication-title: N Engl J Med
– volume: 102
  start-page: 1771
  year: 2010
  end-page: 1779
  ident: r017
  article-title: Baseline characteristics of participants in the randomized National Lung Screening Trial.
  publication-title: J Natl Cancer Inst ;[Erratum, J Natl Cancer Inst 2011;103:1560.]
– volume: 97
  start-page: 1832
  year: 2005
  end-page: 1839
  ident: r021
  article-title: Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
  publication-title: J Natl Cancer Inst
– volume: 365
  start-page: 395
  year: 2011
  end-page: 409
  ident: r002
  article-title: Reduced lung cancer mortality with low-dose computed tomographic screening.
  publication-title: N Engl J Med ;The National Lung Screening Trial Research Team
– volume: 144
  start-page: 33
  year: 2012
  end-page: 38
  ident: r008
  article-title: The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.
  publication-title: J Thorac Cardiovasc Surg
– volume: 155
  start-page: 540
  year: 2011
  end-page: 542
  ident: r014
  article-title: Screening for lung cancer: for patients at increased risk for lung cancer, it works.
  publication-title: Ann Intern Med
– volume: 63
  start-page: 107
  year: 2013
  end-page: 117
  ident: r005
  article-title: American Cancer Society lung cancer screening guidelines.
  publication-title: CA Cancer J Clin
– volume: 4
  start-page: 1778
  year: 2011
  end-page: 1789
  ident: r012
  article-title: Lung cancer risk prediction to select smokers for screening CT: a model based on the Italian COSMOS Trial.
  publication-title: Cancer Prev Res (Phila)
– volume: 309
  start-page: 1163
  year: 2013
  end-page: 1170
  ident: r029
  article-title: Computed tomography screening for lung cancer.
  publication-title: JAMA
– volume: 46
  start-page: 813
  year: 1990
  end-page: 826
  ident: r018
  article-title: Estimates of absolute cause-specific risk in cohort studies.
  publication-title: Biometrics
– volume: 63
  start-page: 11
  year: 2013
  end-page: 30
  ident: r001
  article-title: Cancer statistics, 2013.
  publication-title: CA Cancer J Clin
– volume: 16
  start-page: 385
  year: 1997
  end-page: 395
  ident: r019
  article-title: The lasso method for variable selection in the Cox model.
  publication-title: Stat Med
– volume: 155
  start-page: 537
  year: 2011
  end-page: 539
  ident: r028
  article-title: Screening for lung cancer: it works, but does it really work?
  publication-title: Ann Intern Med
– volume: 99
  start-page: 715
  year: 2007
  end-page: 726
  ident: r024
  article-title: A risk model for prediction of lung cancer.
  publication-title: J Natl Cancer Inst
– volume: 95
  start-page: 470
  year: 2003
  end-page: 478
  ident: r023
  article-title: Variations in lung cancer risk among smokers.
  publication-title: J Natl Cancer Inst
– ident: r027
  article-title: R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2012.
– volume: 307
  start-page: 2434
  year: 2012
  end-page: 2435
  ident: r032
  article-title: Lung cancer screening, radiation, risks, benefits, and uncertainty.
  publication-title: JAMA
– volume: 307
  start-page: 2418
  year: 2012
  end-page: 2429
  ident: r004
  article-title: Benefits and harms of CT screening for lung cancer: a systematic review.
  publication-title: JAMA ;[Erratum, JAMA 2012;308:1324.]
– volume: 24
  start-page: 586
  year: 2013
  end-page: 597
  ident: r006
  article-title: From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French Intergroup (IFCT) and the Groupe d'Oncologie de Langue Francaise (GOLF).
  publication-title: Ann Oncol
– volume: 258
  start-page: 243
  year: 2011
  end-page: 253
  ident: r016
  article-title: The National Lung Screening Trial: overview and study design.
  publication-title: Radiology ;National Lung Screening Trial Research Team
– volume: 19
  start-page: 154
  year: 2012
  end-page: 156
  ident: r011
  article-title: Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
  publication-title: J Med Screen
– volume: 58
  start-page: 1227
  year: 2009
  end-page: 1232
  ident: r003
  article-title: Cigarette smoking among adults and trends in smoking cessation -- United States, 2008.
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 157
  start-page: 571
  year: 2012
  end-page: 573
  ident: r015
  article-title: When the average applies to no one: personalized decision making about potential benefits of lung cancer screening.
  publication-title: Ann Intern Med
– volume: 98
  start-page: 270
  year: 2008
  end-page: 276
  ident: r025
  article-title: The LLP risk model: an individual risk prediction model for lung cancer.
  publication-title: Br J Cancer
– volume: 368
  start-page: 728
  year: 2013
  end-page: 736
  ident: r010
  article-title: Selection criteria for lung-cancer screening.
  publication-title: N Engl J Med
– ident: r033
  article-title: Barnes PM, Ward BW, Freeman G, et al. Early release of selected estimates based on data from the January–March 2011 National Health Interview Survey. National Center for Health Statistics, September 2011 ( http://www.cdc.gov/nchs/nhis.htm ).
– volume: 21
  start-page: 1559
  year: 2002
  end-page: 1573
  ident: r022
  article-title: How should meta-regression analyses be undertaken and interpreted?
  publication-title: Stat Med
– volume: 103
  start-page: 1058
  year: 2011
  end-page: 1068
  ident: r026
  article-title: Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation.
  publication-title: J Natl Cancer Inst
– ident: r032
  doi: 10.1001/jama.2012.6096
– volume: 10
  start-page: 240
  year: 2012
  ident: r007
  publication-title: J Natl Compr Canc Netw
  doi: 10.6004/jnccn.2012.0022
– ident: r013
  doi: 10.1001/2012.jama.11892
– ident: r021
  doi: 10.1093/jnci/dji430
– ident: r028
  doi: 10.7326/0003-4819-155-8-201110180-00364
– ident: r015
  doi: 10.7326/0003-4819-157-8-201210160-00524
– ident: r029
  doi: 10.1001/jama.2012.216988
– ident: r030
  doi: 10.1056/NEJMc1111935
– ident: r018
  doi: 10.2307/2532098
– ident: r022
  doi: 10.1002/sim.1187
– ident: r011
  doi: 10.1258/jms.2012.012010
– ident: r020
  doi: 10.1158/1078-0432.CCR-07-4534
– ident: r002
  doi: 10.1056/NEJMoa1102873
– ident: r008
  doi: 10.1016/j.jtcvs.2012.05.060
– volume: 58
  start-page: 1227
  year: 2009
  ident: r003
  publication-title: MMWR Morb Mortal Wkly Rep
– ident: r005
  doi: 10.3322/caac.21172
– ident: r031
  doi: 10.1056/NEJMe1103776
– ident: r012
  doi: 10.1158/1940-6207.CAPR-11-0026
– ident: r017
  doi: 10.1093/jnci/djq434
– ident: r026
  doi: 10.1093/jnci/djr173
– ident: r016
  doi: 10.1148/radiol.10091808
– ident: r024
  doi: 10.1093/jnci/djk153
– ident: r009
  doi: 10.7326/0003-4819-157-4-201208210-00004
– ident: r019
  doi: 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
– ident: r006
  doi: 10.1093/annonc/mds476
– ident: r001
  doi: 10.3322/caac.21166
– ident: r025
  doi: 10.1038/sj.bjc.6604158
– ident: r014
  doi: 10.7326/0003-4819-155-8-201110180-00367
– ident: r010
  doi: 10.1056/NEJMoa1211776
– ident: r023
  doi: 10.1093/jnci/95.6.470
– ident: r004
  doi: 10.1001/jama.2012.5521
– reference: 24511598 - Rofo. 2014 Jan;186(1):8.
– reference: 24002872 - Dtsch Med Wochenschr. 2013 Sep;138(36):1754. doi: 10.1055/s-0032-1329057.
SSID ssj0000149
Score 2.5970168
Snippet The 60% of patients at highest risk for lung cancer in the National Lung Screening Trial accounted for 88% of the lung-cancer deaths prevented by low-dose CT...
In the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among...
BackgroundIn the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
mms
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 245
SubjectTerms Aged
Biological and medical sciences
Computed tomography
Death
False Positive Reactions
Female
General aspects
Humans
Lung - diagnostic imaging
Lung cancer
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - mortality
Lung Neoplasms - prevention & control
Male
Mass Screening
Medical sciences
Medical screening
Middle Aged
Pneumology
Prevention and actions
Public health. Hygiene
Public health. Hygiene-occupational medicine
Radiation Dosage
Radiography
Risk
Risk assessment
Smoking
Tomography, X-Ray Computed
Tumors of the respiratory system and mediastinum
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoQagX3o9AqYyEOGE1TpzYPiG0peJAqwoWqbcoccZigU3azRb-PjNe77ZBlAtnj_Ka12fPZD7GXtnMeW_rTLQS1aAkeGHz1InMylbnxklwPpBN6ONjc3pqT-KB2xDbKtcxMQTqtnd0Rr5PGwFl0OTU27NzQaxRVF2NFBpb7CZNSchD697JlfFREf7GE6Q4YxNz_j4xzfc1BnDMV3KUk7bm84E6JOsBP5JfsVv8DX7-2UV5JS0d3v3fF7rH7kRAyt-tLOg-uwHdA3b7KJbcH7KjaegVxwzHe88_9r_EQT8An0z5Z0c9O7RAlBMLSoJ82XNElPzTbPgexDGUiAkZ1oIfENh8xL4cvp9OPojIwSBcoeRStAgpMuVaTFppU1jcoOnS29QbUyNwaxymNp1CC1b7WkuABt3Ya0OohCjsIX_Mtru-g6eMN1krczCgoDHKmqJxUDpfKp_mvoWiTtibtRYqFweUE0_GjyoUyouyGiktYa834meryRzXCe6hSqsOvs2vFRhpe3M53LEbg0IJ212rsIouPlSX-kvYy80yOidVXOoO-osggwixtNIm7MnKWi4vnpsSgy3eXY_saCNAg7_HK93saxgAntOvN4V69u_Hes52ssDdoYU0u2x7ubiAF-yW-7mcDYu94Cm_AeZPGLI
  priority: 102
  providerName: ProQuest
Title Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
URI https://nejm.org/doi/full/10.1056/NEJMoa1301851
https://www.ncbi.nlm.nih.gov/pubmed/23863051
https://www.proquest.com/docview/1401480404
https://www.proquest.com/docview/1406176919
https://pubmed.ncbi.nlm.nih.gov/PMC3783654
Volume 369
WOSCitedRecordID wos000321945800010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBGY
  databaseName: New England Journal of Medicine Current
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: DCD
  dateStart: 19900101
  isFulltext: true
  titleUrlDefault: https://www.nejm.org/medical-index
  providerName: Massachusetts Medical Society
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M7P
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Consumer Health Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M0R
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: 7X7
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Healthcare Administration Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M0T
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthmanagement
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: 7RV
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: BENPR
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database (ProQuest)
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M2M
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: 8C1
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M2O
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250909
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M2P
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwEB7tAyEuLG_CLpWRECeijfOyfYR0VxxoqUpBvUWJY4sCTVDT3f37zLhp2QArxOW7eJIo9oznc-zMB_BShdpaVYR-xXEYYm6sr6JA-6HilYik5kZbJzYhxmM5n6vJHpxu_4Wpzdel28CniKYv0Ft1-FPShm8KnHIxw-By5xB9TZFWwzAbXqsX1fHd7pNRV1Tzj8t7SWh_uWzpSGTRYq_YjZzF3_jm78cmr-Wh86P_foN7cLejnOzNxkfuw56pH8DtUbep_hBGM3caHHMYayx731z5w6Y1LJuxj5pO5VADiUqsKM2xdcOQM7Lpov3mzHGy8DNynRUbEp18BJ_Oz2bZO79TWfB1EvO1XyFpCGNdYVoKykThEkykVgVWygKpWakxeYnAVEYJWwhuTImBaoUk3kEi9SZ6DAd1U5unwMqw4pGRJjaljJVMSm1SbdPYBpGtTFJ48Hrb7bnuSpCTEsb33G2FJ2ne6yIPXu3Mf2xqb9xkOMAxzKnnbzToDe_udrgmlxKNPDjZjnfeBXGb09ozljjLxR682DVj-NGeSlGb5sLZIAdMFVcePNm4x6-bRzLF6RSfLnqOszOg0t79lnrxxZX4jujnmiR-9q8XO4Y7odPnED6XJ3CwXl2Y53BLX64X7WoA-2L6mXAuHEpEmfEBHL49G0-mAxc8iKNg6nBGGI4cfnA4IRSTn_xlEww
linkProvider Massachusetts Medical Society
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BQEX3o9AKUYCTljN2_YBIbRL1aq7KwSL1FtIHFtsyyZls6XiT_Ebmclj2yDKrQfOHjkPf55vbI_nA3ihfG2tSn2eezgMoWcsV4Grua-8XARSe0bbWmxCTCby4EB9WINf3V0YSqvsfGLtqPNS0x75Ni0EQomQC98ef-ekGkWnq52ERgOLffPzFJds1Zu9IY7vS9_feT8d7PJWVYDrKPSWPEeS9EOdoxt2s0jhkkPEVrlWyhRDkUyjsxauyY0SNhWeMRkC0wpJPEui7CbAftfhCtXVoxTCsTs9V66qDbfbHau2pifGGNukbF-mSBjIj16PA9fn84oyMtMKB8U2ahp_C3f_zNo8R4M7t_63H3gbbrYBN3vXzJA7sGaKu3Bt3KYU3IPxtM6FRwZnpWWj8pQPy8qwwZR90pSTRA0kqbEgkmfLkmHEzD7OqqPaHF0lH9DEWbAhBdP34fOlfMwD2CjKwjwClvm5FxhpQpPJUMko0ybWNg6tG9jcRKkDr7tRT3RbgJ10QL4ldSJAFCc9kDjwamV-3FQeuchwCyGUFOZwfqFBD12r7nyB7huNHNjsIJO0LqxKzvDiwPNVMzofOlFKC1Oe1DYYAcfKUw48bNB51nkgYyQTfLro4XZlQIXN-y3F7Gtd4Dygq0VR-Pjfr_UMru9Ox6NktDfZfwI3_FqnRHBPbsLGcnFinsJV_WM5qxZb9Sxl8OWyUf0bvY5zPQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BVVceD8CpRgJOBFtnJftQ1WhXVZUbVcVLFJvIXFsscAmZbOl4q_x65jJY9sgyq0Hzh45D3-eb2yP5wN4oXxtrUp9N-c4DCE31lWBp11f8VwEUnOjbS02ISYTeXysjtbgV3cXhtIqO59YO-q81LRHPqCFQCgRcuHAtmkRR6Px7sl3lxSk6KS1k9NoILJvfp7h8q3a2RvhWL_0_fHb6fCd2yoMuDoK-dLNkTD9UOfokr0sUrj8ELFVnpUyxbAk0-i4hWdyo4RNBTcmQ5BaIYlzSaDdBNjvOlwTAaKYbqkP-YXSVW3o3e5etfU9Md4YkMp9mSJ5IFfyHh-uz-cVZWemFQ6QbZQ1_hb6_pnBeYESx7f-5595G262gTh708ycO7BmiruwedimGtyDw2mdI4_MzkrLDsozd1RWhg2n7IOmXCVqIKmNBZE_W5YMI2n2flZ9rc3RhbpDmlALNqIg-z58vJKPeQAbRVmYR8AyP-eBkSY0mQyVjDJtYm3j0HqBzU2UOvC6Q0Ci28LspA_yLakTBKI46QHGgVcr85OmIsllhtsIp6QwX-aXGvSQturOF-jW0ciBrQ4-SevaquQcOw48XzWjU6KTprQw5Wltg5FxrLhy4GGD1PPOAxkjyeDTRQ_DKwMqeN5vKWaf68LnAV05isLH_36tZ7CJYE4O9ib7T-CGX8uXCJfLLdhYLk7NU7iufyxn1WK7nrAMPl01qH8DHGF7uw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+of+Low-Dose+CT+Screening+According+to+the+Risk+of+Lung-Cancer+Death&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Kovalchik%2C+Stephanie+A.&rft.au=Tammemagi%2C+Martin&rft.au=Berg%2C+Christine+D.&rft.au=Caporaso%2C+Neil+E.&rft.date=2013-07-18&rft.issn=0028-4793&rft.eissn=1533-4406&rft.volume=369&rft.issue=3&rft.spage=245&rft.epage=254&rft_id=info:doi/10.1056%2FNEJMoa1301851&rft.externalDBID=n%2Fa&rft.externalDocID=10_1056_NEJMoa1301851
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon